About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Outcomes of Targeted Therapy in EGFR and ALK-Positive NSCLC Brain Metastases
By
Weill Cornell Medicine Courses and Meetings
FEATURING
Manmeet Ahluwalia
By
Weill Cornell Medicine Courses and Meetings
FEATURING
Manmeet Ahluwalia
41 views
June 7, 2019
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
16:02
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024
cfDNA for Liquid Biopsy for Patients With Glioblastoma
Feat.
S. Bagley
13:23
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "A Pooled Analysis of T-DXd for HER2+ mBC Wi…
Feat.
S. Hurvitz
17:33
Henry Friedman
Overview and Updates in Brain Tumors
29:55
Weill Cornell Medicine Courses and Meetings
Medical Treatment for Hormone-Producing Tumors
Feat.
S. Melmed
12:26
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024
2024 Neuro-Oncology Update: NSCLC and Brain Mets
Feat.
T. McGranahan
20:09
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024
Medical and Symptom Management of Patients With Brain Tumors
Feat.
A. Pruitt
08:21
Total Health
Systemic Therapy for HER2+ CNS Disease: Management of Breast Cancer …
Feat.
C. Santa-Maria
05:41
ESMO 2022 Conference Coverage
ESMO 2022 on the DAISY Trial: Antitumor Activity of T-DXd in Patient…
Feat.
N. Epaillard
04:42
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024
2024 Neuro-Oncology Update: Breast Cancer and Brain Mets
Feat.
T. McGranahan
07:34
Marcelo Negrao
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Tr…
18:14
Janakiraman Subramanian
Understanding KRAS G12C Positive Lung Cancer
17:18
Insights from 2023 SABCS
SABCS 2023 Insights: "ELECTRA Study of Elacestrant in Combinati…
Feat.
N. Ibrahim
18:14
ILCC 2022 Conference Coverage
Systemic Therapy for Brain Metastases in NSCLC
Feat.
E. Massarelli
10:29
NYU Langone
FDA Approval of Adagrasib in KRAS G12Cm NSCLC
Feat.
J. Sabari
04:03
Insights from 2023 SABCS
SABCS 2023 Insights: "DEBBRAH Study - Trastuzumab Deruxtecan in…
Feat.
M. Vaz Batista
37:55
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Fred Hutchinson Cancer Center Updates on CNS Tumors
Feat.
V. Venur
05:02
Total Health
CNS Metastasis in Breast Cancer: Surgery & Radiation Considerati…
Feat.
C. Santa-Maria
12:52
Penn Medicine Abramson Cancer Center
Penn Medicine Updates in Oncology 2023: Brain Tumors
Feat.
S. Bagley
20:10
Insights from 2023 ESMO Annual Meeting
Systemic Therapy of CNS Disease in HER2+ BC
Feat.
S. Lee
33:35
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024
Developing Novel Therapeutics for Brain Tumors in the Age of Genomic…
Feat.
E. Galanis
